covid-19 information vaccine

Hackensack Meridian partners with Merck for Covid-19 research

Reading now: 491
www.pharmaceutical-technology.com

Sign up here for GlobalData's free bi-weekly Covid-19 report on the latest information your industry needs to know.The Hackensack Meridian Center for Discovery and Innovation (CDI) has entered into a research alliance with Merck to explore drugs for the treatment of Covid-19.

Currently, the disease lacks an approved vaccine and broadly effective antiviral therapy, indicating the need for an effective drug to fight the ongoing pandemic.

As part of the research collaboration, Hackensack Meridian CDI and Merck will work to discover drug candidates that can help treat Covid-19.

Hackensack Meridian CDI will combine its expertise in academic drug discovery and viral pathogens analysis with Merck’s capabilities to discover and develop.

Read more on pharmaceutical-technology.com
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News

DMCA